1-4 of 4
Connie Eaves, PhD.
Close
Sort by
Journal Articles

Properties of CD34 + CML Cells That Predict Clinical Response to Tyrosine Kinase Inhibitors.

Xiaoyan Jiang, MD, PhD, Donna Forrest, MD, Franck Nicolini, MD, PhD, Karen Lambie, Kyi Min Saw, Emily Pang, Ranko Vukovic, Clayton Smith, MD, Allen Eaves, MD, PhD, Connie Eaves, PhD
Journal: Blood
Blood (2007) 110 (11): 324.
https://doi.org/10.1182/blood.V110.11.324.324
Published: 2007
Journal Articles

Chronic Myeloid Leukemia Stem Cells Possess Unique Properties That Predict Intrinsic and Acquired Resistance to Imatinib Mesylate.

Xiaoyan Jiang, MD, PhD, Yun Zhao, PhD, Clayton Smith, MD, Maura Gasparetto, MD, Kyi Min Saw, Ali Turhan, MD, PhD, Allen Eaves, MD, PhD, Connie Eaves, PhD
Journal: Blood
Blood (2006) 108 (11): 752.
https://doi.org/10.1182/blood.V108.11.752.752
Published: 2006
Journal Articles

Leukemic Stem Cells of Chronic Phase CML Patients Possess Uniquely Elevated BCR-ABL Kinase Activity and Acquire Spontaneous BCR-ABL Kinase Domain Mutations at a High Frequency.

Xiaoyan Jiang, MD, PhD, Kyi Min Saw, Allen Eaves, MD, PhD, Connie Eaves, PhD
Journal: Blood
Blood (2005) 106 (11): 438.
https://doi.org/10.1182/blood.V106.11.438.438
Published: 2005
Journal Articles

Leukemic Stem Cells of Chronic Phase CML Patients Consistently Display Very High BCR-ABL Transcript Levels and Reduced Responsiveness to Imatinib Mesylate in Addition to Generating a Rare Subset That Produce Imatinib Mesylate-Resistant Differentiated Progeny.

Xiaoyan Jiang, MD, PhD, Yun Zhao, PhD, Wing Yiu Chan, Emily Pang, Allen Eaves, MD, PhD, Connie Eaves, PhD.
Journal: Blood
Blood (2004) 104 (11): 711.
https://doi.org/10.1182/blood.V104.11.711.711
Published: 2004